Research programme: diabetes protein therapeutics - Five Prime TherapeuticsAlternative Names: FPT 038
Latest Information Update: 18 Jun 2012
At a glance
- Originator Five Prime Therapeutics
- Class Antibodies; Proteins
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Diabetes mellitus